亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

安慶奇創(chuàng)藥業(yè)有限公司  

替尼、列凈、列汀、沙班等系列中間體研發(fā)、生產(chǎn)、銷售

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:曹磊
  • 電話:18251981946
  • 郵件:caolei@chicopharm.com
  • 傳真:安慶奇創(chuàng)藥業(yè)有限公司
  • QQ:2765648527
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 阿哌沙班中間體A CAS NO 1267610-26-3
阿哌沙班中間體A CAS NO 1267610-26-3
單價 21.00 / KG對比
銷量 暫無
發(fā)貨 安徽安慶市付款后3天內(nèi)
庫存 232333KG起訂1KG
品牌 chico
含量 ≥99%
過期 長期有效
更新 2022-01-17 14:01
 
詳細(xì)信息
  • 英文名稱:

  • 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone

  • CAS號:

  • 1267610-26-3

  • 分子式:

  • C15H19N3O2

  • 分子量:

  • 273.33

©2025 安慶奇創(chuàng)藥業(yè)有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:13400  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |